Raymond James upgraded Marsh McLennan (MRSH) to Strong Buy from Outperform with a price target of $225, down from $240. Marsh’s high-quality earnings profile, consistent margin expansion, and strongest credit metrics in the peer group position it as an attractive risk-reward upgrade candidate following the valuation reset, the analyst tells investors in a research note. With limited exposure to ongoing Howden-related litigation, industry-low CDS spreads, and guidance for mid-single-digit organic growth alongside a 19th consecutive year of margin expansion, the company remains well supported by digital infrastructure demand, AI-related client investment, and productivity gains from its Thrive initiative, the firm says.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRSH:
- Execution Risks Cloud Marsh & McLennan’s Thrive and BCS Efficiency Plans
- Marsh McLennan price target raised to $205 from $201 at Citi
- Marsh McLennan subsidiary acquires Robinson & Son, terms not disclosed
- Marsh McLennan price target raised to $212 from $208 at Cantor Fitzgerald
- Marsh McLennan price target raised to $213 from $212 at Mizuho
